Analyze Diet
Veterinary pathology2004; 41(2); 95-100; doi: 10.1354/vp.41-2-95

Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs.

Abstract: Severe combined immunodeficiency (SCID) is an inherited disorder of humans, mice, horses, and dogs, in which affected individuals are incapable of generating antigen-specific immune responses. It occurs when lymphocyte precursors fail to differentiate into mature lymphocytes because of mutations within recombinase-activating genes 1 and 2 or within the genes encoding deoxyribonucleic acid (DNA)-dependent protein kinase (DNA-PK). It also occurs when differentiated lymphocytes are incapable of completing signal transduction pathways because of defects in cell surface receptors for interleukins (IL). A spontaneous mutation in DNA-PKcs of BALB/c mice results in SCID, as do experimentally induced mutations in RAG1 and RAG2. SCID in horses results from a spontaneous mutation in DNA-PKcs. Two molecular mechanisms account for SCID in dogs. Jack Russell Terriers have a mutation within the DNA-PKcs gene, whereas Cardigan Welsh Corgi and Basset Hound have different defects in the gene encoding the gamma chain that is common to the receptors for IL-2, -4, -7, -9, -15, and -21. The location of the mutation within target genes influences the spectrum of diseases observed in affected animals.
Publication Date: 2004-03-16 PubMed ID: 15017021DOI: 10.1354/vp.41-2-95Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates the molecular causes of severe combined immunodeficiency (SCID) in different animals including mice, horses, and dogs, revealing that the disorder occurs due to mutations within certain genes that hampers normal immune responses.

Understanding Severe Combined Immunodeficiency (SCID)

  • SCID is an inherited disorder that impacts the immune system.
  • It affects humans, mice, horses, and dogs, making them incapable of generating specific immune responses.
  • The disorder comes into play when lymphocyte precursors, which should naturally develop into mature lymphocytes, fail to do so.
  • This failure is attributed to mutations within certain genes, namely, recombinase-activating genes 1 and 2 (RAG1 and RAG2) or genes encoding DNA-dependent protein kinase (DNA-PK).
  • Another way SCID manifests is when mature lymphocytes cannot complete signal transduction pathways due to defects in cell surface receptors for interleukins (IL), crucial proteins that regulate the immune system.

Role of Different Genes in SCID Formation

  • A spontaneous mutation in the DNA-PKcs of a BALB/c mice type results in SCID which is similar to the situational occurrence when experimentally induced mutations in RAG1 and RAG2 are present.
  • Spontaneous mutation in DNA-PKcs is also the causes SCID in horses.

Types of Mutations Causing SCID in Different Dogs

  • The research discovered two molecular mechanisms that lead to SCID in dogs, with each related to a particular breed.
  • In Jack Russell Terriers, a mutation within the DNA-PKcs gene causes the disorder.
  • Conversely, Cardigan Welsh Corgi and Basset Hound breeds have different defects in the gene encoding the gamma chain common to the receptors for several interleukins; specifically IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.

Effect of Mutation Location Within Target Genes

  • The location of the mutation within the target genes (RAG1, RAG2, or DNA-PKcs) significantly influences the range of diseases that can manifest in the affected animals.

Cite This Article

APA
Perryman LE. (2004). Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs. Vet Pathol, 41(2), 95-100. https://doi.org/10.1354/vp.41-2-95

Publication

ISSN: 0300-9858
NlmUniqueID: 0312020
Country: United States
Language: English
Volume: 41
Issue: 2
Pages: 95-100

Researcher Affiliations

Perryman, L E
  • College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1601, USA. lance.perryman@colostate.edu.

MeSH Terms

  • Animals
  • DNA-Activated Protein Kinase
  • DNA-Binding Proteins
  • Dog Diseases / genetics
  • Dogs
  • Genes, RAG-1 / genetics
  • Genes, Recessive / genetics
  • Horse Diseases / genetics
  • Horses
  • Immunoglobulin gamma-Chains / genetics
  • Lymphocytes / pathology
  • Mice
  • Mutation / genetics
  • Protein Serine-Threonine Kinases / genetics
  • Rodent Diseases / genetics
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / veterinary
  • Signal Transduction / genetics

Citations

This article has been cited 15 times.
  1. Reich P, Falker-Gieske C, Pook T, Tetens J. Development and validation of a horse reference panel for genotype imputation.. Genet Sel Evol 2022 Jul 4;54(1):49.
    doi: 10.1186/s12711-022-00740-8pubmed: 35787788google scholar: lookup
  2. Koike M, Yutoku Y, Koike A. Feline XRCC4 undergoes rapid Ku-dependent recruitment to DNA damage sites.. FEBS Open Bio 2022 Apr;12(4):798-810.
    doi: 10.1002/2211-5463.13363pubmed: 35000298google scholar: lookup
  3. Kim YY, Kim JS, Che JH, Ku SY, Kang BC, Yun JW. Comparison of Genetically Engineered Immunodeficient Animal Models for Nonclinical Testing of Stem Cell Therapies.. Pharmaceutics 2021 Jan 20;13(2).
    doi: 10.3390/pharmaceutics13020130pubmed: 33498509google scholar: lookup
  4. Switonski M. Impact of gene therapy for canine monogenic diseases on the progress of preclinical studies.. J Appl Genet 2020 May;61(2):179-186.
    doi: 10.1007/s13353-020-00554-8pubmed: 32189222google scholar: lookup
  5. Powell EJ, Charley S, Boettcher AN, Varley L, Brown J, Schroyen M, Adur MK, Dekkers S, Isaacson D, Sauer M, Cunnick J, Ellinwood NM, Ross JW, Dekkers JC, Tuggle CK. Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs.. Lab Anim 2018 Aug;52(4):402-412.
    doi: 10.1177/0023677217750691pubmed: 29325489google scholar: lookup
  6. Powell EJ, Cunnick JE, Tuggle CK. SCID pigs: An emerging large animal NK model.. J Rare Dis Res Treat 2017;2(3):1-6.
    pubmed: 29152615
  7. Powell EJ, Graham J, Ellinwood NM, Hostetter J, Yaeger M, Ho CS, Gault L, Norlin V, Snella EN, Jens J, Waide EH, Boettcher AN, Kerrigan M, Rowland RRR, Ross JW, Dekkers JCM, Tuggle CK. T Cell Lymphoma and Leukemia in Severe Combined Immunodeficiency Pigs following Bone Marrow Transplantation: A Case Report.. Front Immunol 2017;8:813.
    doi: 10.3389/fimmu.2017.00813pubmed: 28747915google scholar: lookup
  8. Rajao DS, Loving CL, Waide EH, Gauger PC, Dekkers JC, Tuggle CK, Vincent AL. Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.. J Innate Immun 2017;9(2):193-202.
    doi: 10.1159/000451007pubmed: 27988511google scholar: lookup
  9. Brauer PM, Pessach IM, Clarke E, Rowe JH, Ott de Bruin L, Lee YN, Dominguez-Brauer C, Comeau AM, Awong G, Felgentreff K, Zhang YH, Bredemeyer A, Al-Herz W, Du L, Ververs F, Kennedy M, Giliani S, Keller G, Sleckman BP, Schatz DG, Bushman FD, Notarangelo LD, Zúñiga-Pflücker JC. Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.. Blood 2016 Aug 11;128(6):783-93.
    doi: 10.1182/blood-2015-10-676304pubmed: 27301863google scholar: lookup
  10. Powell EJ, Cunnick JE, Knetter SM, Loving CL, Waide EH, Dekkers JC, Tuggle CK. NK cells are intrinsically functional in pigs with Severe Combined Immunodeficiency (SCID) caused by spontaneous mutations in the Artemis gene.. Vet Immunol Immunopathol 2016 Jul;175:1-6.
    doi: 10.1016/j.vetimm.2016.04.008pubmed: 27269786google scholar: lookup
  11. Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL. Companion animals: Translational scientist's new best friends.. Sci Transl Med 2015 Oct 7;7(308):308ps21.
    doi: 10.1126/scitranslmed.aaa9116pubmed: 26446953google scholar: lookup
  12. Lin YF, Nagasawa H, Little JB, Kato TA, Shih HY, Xie XJ, Wilson PF Jr, Brogan JR, Kurimasa A, Chen DJ, Bedford JS, Chen BP. Differential radiosensitivity phenotypes of DNA-PKcs mutations affecting NHEJ and HRR systems following irradiation with gamma-rays or very low fluences of alpha particles.. PLoS One 2014;9(4):e93579.
    doi: 10.1371/journal.pone.0093579pubmed: 24714417google scholar: lookup
  13. Bauer TR Jr, Adler RL, Hickstein DD. Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.. ILAR J 2009;50(2):168-86.
    doi: 10.1093/ilar.50.2.168pubmed: 19293460google scholar: lookup
  14. Maser RS, Wong KK, Sahin E, Xia H, Naylor M, Hedberg HM, Artandi SE, DePinho RA. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse.. Mol Cell Biol 2007 Mar;27(6):2253-65.
    doi: 10.1128/MCB.01354-06pubmed: 17145779google scholar: lookup
  15. Camargo MM, Nahum LA. Adapting to a changing world: RAG genomics and evolution.. Hum Genomics 2005 Jun;2(2):132-7.
    doi: 10.1186/1479-7364-2-2-132pubmed: 16004728google scholar: lookup